Evaluation of matrix metalloproteinases and their endogenous tissue inhibitors in biliary atresia-associated liver fibrosis

Journal of Pediatric Surgery

Volumn 40, Issue 10, 2005, Pages 1568-1573

  Hsieh, Chih Sung ^a   Chuang, Jiin Haur ^a,b   Huang, Chao Cheng ^a   Chou, Ming Huei ^b   Wu, Chia Lin ^b   Lee, Shin Yi ^a   Chen, Chao Long ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Biliary atresia; Liver fibrosis DNA microarray; Matrix metalloproteinase; Real time QRT PCR; Tissue inhibitor of metalloproteinase

Indexed keywords

GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ADOLESCENT; ARTICLE; BILE DUCT ATRESIA; CASE REPORT; CHILD; DIFFERENTIAL DISPLAY; DISEASE COURSE; DNA MICROARRAY; DOWN REGULATION; FEMALE; GEL ELECTROPHORESIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; INFANT; INTERMETHOD COMPARISON; LIVER; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; MOLECULAR CLONING; PORTOENTEROSTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; UPREGULATION; VALIDATION PROCESS;

BILIARY ATRESIA; FEMALE; HUMANS; INFANT; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 27444434425     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2005.06.028     Document Type: Article

References (29)

1. F.M. Karrer, M.R. Price, and D.D. Bensard Long-term results with the Kasai operation for biliary atresia Arch Surg 131 1996 493 496
2. M. Nio, R. Ohi, and S. Shimaoka The outcome of surgery for biliary atresia and the current status of long-term survivors Tohoku J Exp Med 181 1997 235 244
3. C.L. Chen, Y.S. Chen, and V.H. de Villa Minimal blood loss living donor hepatectomy Transplantation 69 2000 2580 2586
4. A. Jain, J. Reyes, and R. Kashyap Long-term survival after liver transplantation in 4,000 consecutive patients at a single center Ann Surg 232 2000 490 500
5. C.M. Miller, G.E. Gondolesi, and S. Florman One hundred nine living donor liver transplants in adults and children: a single-center experience Ann Surg 234 2001 301 311
6. S.L. Friedman, J.J. Maher, and D.M. Bissell Mechanisms and therapy of hepatic fibrosis: report of the AASLD single topic basic research conference Hepatology 32 2000 1403 1408
7. R.C. Benyon, and M.J.P. Arthur Extracellular matrix degradation and the role of hepatic stellate cells Semin Liver Dis 21 2001 373 384
8. A. Faiz Kabir Uddin Ahmed, H. Ohtani, and M. Nio In situ expression of fibrogenic growth factors and their receptors in biliary atresia: comparison between early and late stages J Pathol 192 2000 73 80
9. A.F. Ahmed, M. Nio, and H. Ohtani Clinical significance of c-kit expression in biliary atresia Pediatr Surg Int 17 2001 601 603
10. C. Liu, J.H. Chiu, and T.W. Chin Expression of aminopeptidase N in bile canaliculi: a predictor of clinical outcome in biliary atresia J Surg Res 10 2001 76 83
11. M. Davenport, C. Gonde, and R. Redkar Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia J Pediatr Surg 36 2001 1017 1025
12. J.N. Rosensweig, M. Omori, and K. Page Transforming growth factor-beta 1 in plasma and liver of children with liver disease Pediatr Res 44 1998 402 409
13. S.Y. Lee, J.H. Chuang, and C.C. Huang Identification of transforming growth factors actively transcribed during the progress of liver fibrosis in biliary atresia J Pediatr Surg 39 2004 702 708
14. J.A. Bezerra, G. Tiao, and F.C. Ryckman Genetic induction of proinflammatory immunity in children with biliary atresia Lancet 360 2002 1653 1659
15. L. Chen, A. Goryachev, and J. Sun Altered expression of genes involved in hepatic morphogenesis and fibrogenesis are identified by cDNA microarray analysis in biliary atresia Hepatology 38 2003 567 576
16. L. Ferrell Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems Mod Pathol 13 2000 679 704
17. C.C. Huang, J.H. Chuang, and L.L.H. Huang The human Delta-like 1 homologue is implicated in the progression of liver fibrosis in biliary atresia J Pathol 202 2004 172 179
18. R. Cursio, B. Mari, and K. Louis Rat liver injury after normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor FASEB J 16 2002 93 95
19. K.H. Boker, B. Pehle, and C. Steinmetz Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis Hepatogastroenterology 47 2000 812 819
20. R.C. Benyon, J.P. Iredale, and S. Goddard Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver Gastroenterology 110 1996 821 831
21. P. Baldi, and A.D. Long A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes Bioinformatics 17 2001 509 519
22. B. Vaillant, M.G. Chiaramonte, and A.W. Cheever Regulation of hepatic fibrosis and extracellular matrix genes by the th response: new insight into the role of tissue inhibitors of matrix metalloproteinases J Immunol 167 2001 7017 7026
23. A.E. Kossakowska, D.R. Edwards, and S.S. Lee Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis Am J Pathol 153 1998 1895 1902
24. R. Lichtinghagen, D. Michels, and C.I. Haberkorn Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C J Hepatol 34 2001 239 247
25. B.H. Choe, K.M. Kim, and S. Kwon The pattern of differentially expressed genes in biliary atresia J Korean Med Sci 18 2003 392 396
26. H. Herbst, T. Wege, and S. Milani Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis Am J Pathol 150 1997 1647 1659
27. H. Kobayashi, Z.X. Li, and A. Yamataka Clinical evaluation of serum levels of matrix metalloproteinase and tissue inhibitors of metalloproteinase as predictors of progressive fibrosis in postoperative biliary atresia patients J Pediatr Surg 37 2002 1030 1033
28. J.A. Uria, A.A. Ferrando, and G. Velasco Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family Cancer Res 54 1994 2091 2094
29. M.B. Bansal, and S.L. Friedman The enlarging role of matrix metalloproteinases in liver injury-beyond scar degradation J Hepatol 37 2002 293 294